Find, compare & contact
Hydrotalcite
API Manufacturers & Suppliers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Hydrotalcite API 12304-65-3?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Hydrotalcite. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Hydrotalcite
- Synonyms:
- Cas Number:
- 12304-65-3
- DrugBank number:
- DB13322
- Unique Ingredient Identifier:
- 17432CG1KU
General Description:
Hydrotalcite is a chemical compound identified by the CAS number 12304-65-3. It is known for its distinct pharmacological properties and applications.
Classification:
Hydrotalcite belongs to the class of organic compounds known as organic carbonic acids. These are compounds comprising the carbonic acid functional group, classified under the direct parent group Organic carbonic acids. This compound is a part of the Organic compounds, falling under the Organic acids and derivatives superclass, and categorized within the Organic carbonic acids and derivatives class, specifically within the Organic carbonic acids subclass.
Categories:
Hydrotalcite is categorized under the following therapeutic classes: Alimentary Tract and Metabolism, Alkalies, Aluminium Compounds, Aluminum and magnesium containing antacids, Anions, Antacids, Drugs for Acid Related Disorders, Electrolytes, Gastric Acid Lowering Agents, Gastrointestinal Agents, Hydroxides, Ions, Magnesium Compounds, Metal cations, Metal divalent cations. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
Hydrotalcite is a type of Gastrointestinal Agents
Gastrointestinal Agents belong to the pharmaceutical API category that focuses on treating disorders and ailments related to the digestive system. These agents play a crucial role in addressing various gastrointestinal conditions, such as acid reflux, ulcers, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD).
One of the key types of gastrointestinal agents is proton pump inhibitors (PPIs), which work by reducing the production of stomach acid. PPIs help in treating conditions like gastroesophageal reflux disease (GERD) and peptic ulcers. Another essential class of agents is antacids, which neutralize excessive stomach acid, providing relief from heartburn and indigestion.
Gastrointestinal agents also include antispasmodics that alleviate abdominal cramps and spasms associated with conditions like IBS. These drugs work by relaxing the smooth muscles of the digestive tract. Additionally, there are drugs categorized as laxatives that aid in relieving constipation by promoting bowel movements.
Moreover, certain gastrointestinal agents act as antiemetics, effectively reducing nausea and vomiting. These drugs are particularly useful for patients undergoing chemotherapy or experiencing motion sickness.
Pharmaceutical companies develop and manufacture a wide range of gastrointestinal agents in various forms, including tablets, capsules, suspensions, and injections. These agents are typically formulated using active pharmaceutical ingredients (APIs) and other excipients to ensure their efficacy and safety.
In conclusion, gastrointestinal agents form a vital category of pharmaceutical APIs, providing relief from digestive disorders and improving overall gastrointestinal health. The availability of diverse agents catering to different conditions ensures that patients can receive targeted treatment for their specific gastrointestinal needs.
